PTGX

NASDAQStock

Protagonist Therapeutics, Inc.

$96.17-0.39 (-0.40%)

52-Week Range

$40.89

$97.05

Key Stats

Market Cap

6.1B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.24

Volume

467.9K

Avg Volume

703.2K

Performance

+14.29%

+0.66%

+63.45%

YTD

+9.45%

+73.81%

+277.45%

+209.50%

Price Chart

ETF Exposure

PTGX is held by 130 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DFUS	Dimensional - US Equity Market ETF	0.01%	14,318	$1.4M	$18.80B	0.09%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.01%	1,126	$105K	$1.43B	0.09%
VTHR	Vanguard Russell 3000 ETF	0.01%	4,796	$392K	$5.50B	0.06%
TILT	FlexShares Morningstar U.S. Market Factor Tilt Index Fund	0.01%	1,127	$109K	$1.90B	0.26%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.01%	35	$3K	$26.4M	0.50%
VLU	State Street SPDR S&P 1500 Value Tilt ETF	0.01%	326	$32K	$618.9M	0.12%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	31	$3K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	21	$2K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	16	$2K	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	7	$673	$9.5M	0.12%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	38	$4K	$59.0M	0.11%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	1,316	$128K	$2.84B	0.19%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	1,147	$111K	$3.28B	0.20%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	16	$2K	$33.4M	0.34%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	11	$1K	$30.3M	0.32%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	28	$3K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	32	$3K	$64.1M	0.11%
LVHB	Innovator Laddered Allocation Power Buffer ETF	0.00%	14,265	$349K	$782.6M	0.10%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	130	$13K	$733.2M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	397	$39K	$1.69B	0.20%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	2	$160	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	2	$197	$8.3M	0.31%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	16	$2K	$81.5M	0.10%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	27	$3K	$694.1M	0.23%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	5	$475	$61.4M	0.09%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	848	$70K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	848	$70K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	848	$70K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	848	$70K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	848	$70K	$3.7M	0.70%

PreviousPage 3 of 3

About PTGX ETF Exposure

Protagonist Therapeutics, Inc. (PTGX) is held by 130 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.1B, PTGX is a widely held institutional stock. The stock currently trades at $96.17. Investors can gain exposure to PTGX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PTGX, sorted by portfolio weight.